NASDAQ:CLRB

Cellectar Biosciences Stock Predictions

etoro logo Buy CLRB
*Your capital is at risk
$2.60
-0.140 (-5.11%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CLRB Prediction Chart

CLRB Predictions History

Latest community submissions for CLRB.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 5, 2025 $0.443 -4.06% $0.408 V 91.46% 1
Jun 5, 2025 $0.450 -2.54% $0.408 V 89.74% 1
Jun 5, 2025 Bullish $0.408 X 0
Jun 5, 2025 $1.00 +260.23% Unrealistic Excluded from avg $0.408 V 0.00% 0
Feb 27, 2025 $0.300 +4.23% $0.288 X 95.73% 0
Feb 27, 2025 $0.295 +2.65% $0.288 X 97.32% 0
Feb 27, 2025 $10.00 +3 377.05% Unrealistic Excluded from avg $0.288 X 0.00% 0
Feb 4, 2025 Bullish $0.260 X 0
Jan 29, 2024 $3.62 -3.33% $4.21 X 86.10% 0
Jan 29, 2024 $3.67 -2.08% $4.21 X 87.22% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLRB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CELLECTAR BIOSCIENCES
Cellectar Biosciences
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE